Kite Pharma appoints Chris Nowers as its head of Europe
A seasoned executive with 30 years of commercial leadership experience in pharmaceutical, biotech and diagnostics companies, Mr. Nowers brings a track record of successfully driving differentiated strategies for product commercialization across therapeutic areas in a competitive global landscape.
Prior to joining Kite, Mr. Nowers held senior commercial leadership positions at Bristol-Myers Squibb, including Head of Immuno-oncology and Hematology in France, where he led the successful launch of Opdivo (nivolumab), and as Vice President of Global Commercialization for Yervoy (ipilimumab), where he led the global commercial launch.
Previously, Mr. Nowers was Vice President of Sales and Marketing at Genomic Health, Inc., and Chief Executive Officer of Avantogen Oncology Inc., a company developing early-stage cancer therapeutics.
He also served 11 years at Amgen Inc. in a variety of commercial leadership roles, including Global Commercial Leader for Neurology and European Director for Oncology and Hematology. ■
What to read next
LATEST MOVES FROM California
- Peregrine Pharmaceuticals appoints Mark R. Bamforth to boards
- Endologix appoints John Onopchenko as COO
- Depomed appoints Santosh J. Vetticaden as CSO
- Wells Fargo names Michael Roemer as chief compliance officer
- ARMO BioSciences appoints Joseph Leveque as CMO
More inside POST